Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

HIKAL CHEMIC Gains 5%; BSE HEALTHCARE Index Up 0.2%
Wed, 24 Jul 9:49

HIKAL CHEMIC Gains 5%; BSE HEALTHCARE Index Up 0.2%Image source: Sefa Ozel/www.istockphoto.com

HIKAL CHEMIC share price has zoomed 5% and is presently trading at Rs 366.2.

Meanwhile, the BSE HEALTHCARE index is at 38,811.1 (up 0.2%).

Among the top gainers in the BSE HEALTHCARE index today are Sanofi India (up 3.0%) and ALEMBIC PHARMA (up 2.8%).

Torrent Pharma (down 3.2%) and DR. LAL PATHLABS (down 2.1%) are among the top losers today.

Over the last one year, HIKAL CHEMIC has moved up from Rs 280.5 to Rs 366.2, registering a gain of Rs 85.7 (up 30.6%).

On the other hand, the BSE HEALTHCARE index has moved up from 26,789.0 to 38,811.1, registering a gain of 44.9% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were GSK Pharma (up 95.8%), Jubilant Pharmova (up 94.5%) and Lupin (up 92.8%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 80,217.5 (down 0.3%).

The top losers among the BSE Sensex today are Hindustan Unilever (down 3.0%) and Bajaj Finance (down 2.3%). The most traded stocks in the BSE Sensex are ITC and Tata Steel.

In the meantime, NSE Nifty is at 24,409.1 (down 0.3%). Hindustan Unilever and Tata Consumer Products are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,384.8 to 80,217.5, registering a gain of 13,832.7 points (up 20.8%).

HIKAL CHEMIC Financial Update...

HIKAL CHEMIC net profit fell 5.6% YoY to Rs 340 million for the quarter ended March 2024, compared to a profit of Rs 360 million a year ago. Net sales declined 5.7% to Rs 5,141 million during the period as against Rs 5,453 million in January-March 2023.

For the year ended March 2023, HIKAL CHEMIC reported 51.2% decrease in net profit to Rs 784 million compared to net profit of Rs 1,605 million during FY22. Revenue of the company grew 4.1% to Rs 20,230 million during FY23.

The current Price to earnings ratio of HIKAL CHEMIC, based on rolling 12 month earnings, stands at 64.9.


Equitymaster requests your view! Post a comment on "HIKAL CHEMIC Gains 5%; BSE HEALTHCARE Index Up 0.2%". Click here!